In order to evaluate the anticancer activities and understand the mechanism of action, compounds 1–17 were profiled against a panel of luciferase reporter genes that assessed the activity of complex cancer-related signaling transduction pathways, using T98G glioblastoma multiforme cells (i.e., transcription factors; TF; Scheme 5). The gene discussed is TF; the disease is glioblastoma.